Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New System Detects Multiple Biomolecular Interactions

By Biotechdaily staff writers
Posted on 06 Feb 2003
A new tool for pharmaceutical developers is a system that incorporates laser technologies, advanced electronics, microfluidics, and proprietary biochips and software to detect and analyze specific biomolecular interactions.

Called VeriScan, the MEMS (micro-electronic mechanical systems)-based biosensor is capable of detecting interactions with parts-per-trillion sensitivity. More...
Detection is based on recent discoveries that adsorption of proteins creates molecular scale stresses. These stresses can be detected using miniature, micro-machined, mass-produced silicon structure known as microcantilevers. The Veri-Scan 300 monitors the movement of microcantilevers, which are smaller than the width of human hair, by focusing tiny laser beams on the free ends of the microcantilevers.

The VeriScan was developed by Protiveris, Inc. (Rockville, MD, USA; www.protiveris.com). The company employs an array of microcantilevers with customizable surfaces that measure distinct label-free biomolecular interactions, including protein-protein, protein-DNA, and receptor-ligand interactions in its consumable products and disposable biochips. Protiveris is working with customers to develop proteomic-based research including receptor-ligand, immunologic, and metabolism studies.

"The beauty of our technology is that it offers real-time simultaneous detection of multiple protein assays with high sensitivity and selectivity without the use of any external labels,” said Sebastian Kossek, chief science officer, Protiveris.




Related Links:
Protiveris

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.